Navigation Links
Dragon Announces R&D Achievement in Biotech Manufacturing Process
Date:10/31/2007

VANCOUVER, Oct. 31 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. (TSX: DDD; OTCBB: DRUG; BBSE: DRP) today announced that its biotech method for 7ACA production has been successfully implemented on a new production line. Management believes this achievement validates the Company's research and development efforts to improve its manufacturing technology. This technology would bring immediate benefits to production operations by increasing production efficiency and by eliminating the use of chemicals thus reducing our disposal costs and protecting the environment. Further, we believe that the overall adoption of the technology in our operations will reduce production costs which would enhance the Company's competitiveness in global market.

Environmental protection issues are always challenging to the chemical manufacturers. Investments in waste treatment can provide solutions to comply with discharging regulations, but result in relatively higher high costs. Our implementation of biotech technology can assist in reducing this environmental waste.

7ACA is a key product of the Company and the traditional chemical manufacturing process involves the use of expensive solvents, toxic and pollutant reactants such as methylene chloride, N,N-dimethylaniline and trimethylchlorosilicane, which lead to toxic wastes that are difficult to recycle and costly to be properly discharged. Moreover, it must be operated under severe temperature conditions (-40 degrees C to -60 degrees C) for complex chemical reactions, and thus result in high energy costs.

Under the biotech method, enzymes will be used to catalyze reactions, therefore eliminating the use of expensive solvents and toxic reagents, leading to a considerable reduction in the waste generation. In addition, the biotech process operates at moderate temperature which consumes less energy.

Dragon has been dedicated to this biotech project since mid 2006 and has gone through trials. Further, samp
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Chinese pharma-biotech dragon rears its head
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013 Senomyx , ... proprietary taste science technologies to discover, develop, and commercialize ... Linemeyer , Ph.D., the Company,s Vice President, Biology ... Investor Relations & Corporate Communications, will present an overview ... at 10:25 a.m. Eastern Time (7:25 a.m. Pacific Time) ...
(Date:5/24/2013)... 2013 Vestiage, Inc. (stock symbol ... on science-based research and development, sales and marketing ... nutraceuticals, announced today that it is awarding exclusive ... sale of Reluma Skin Illuminating Facial Care. Qualified ... by sending an email to info(at)vestiageinc(dot)com and putting ...
(Date:5/23/2013)... , May 23, 2013 Venaxis, Inc. (Nasdaq: ... focused on obtaining FDA clearance and commercializing its rapid, ... the pricing of an underwritten public offering of 10,000,000 ... purchase 3,500,000 shares of its common stock at an ... public offering price of $1.25 per share and related ...
(Date:5/23/2013)... Patheon Inc ., a leading provider of contract ... will host a complimentary webinar on “Cleaning Validation: Science, ... 4, 2013 at 11 a.m. Eastern Standard Time. ... regulations for cleaning validation. Many companies have incorporated ... evaluation of risk. Some companies have chosen to ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... Mass., Sept. 4 Hologic, Inc.,(Nasdaq: HOLX ) ... presenting at the Morgan Stanley Global Healthcare Unplugged,Conference being ... in New,York, NY., Interested parties are invited to ... on Tuesday, September 9, 2008, at 1:35 PM.,Eastern Time ...
... InVitria,( http://www.invitria.com ), a leading ... enhance productivity, safety and time to ... culture, life science research and,diagnostics industry, ... 4th Annual "Optimizing Cell Culture Development" ...
... Second Round of Funding Supports Commercialization of Recently FDA-cleared ... Pathwork(R) Tissue of ... a,molecular diagnostics company focused on oncology, announced the closing,today of ... the heels of FDA,s clearance for the Pathwork(R) Tissue of ...
Cached Biology Technology:Hologic to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2InVitria Sponsors Cambridge Healthtech's Optimizing Cell Culture Development Conference 2Pathwork Diagnostics Closes $20M Financing 2
(Date:5/23/2013)... and fastest growing open-access publishers, announces the launch ... and Biotechnology . , A broad scope ... and Biotechnology will provide a single open-access ... research to be disseminated and discussed. , ... provide an open-science and interactive web platform for ...
(Date:5/22/2013)... (NLST) investigators also conclude that the 20 percent ... tomography (LDCT) versus chest X-ray (CXR) screening previously ... at experienced screening centers in the United States. ... with their patients about the benefits and risks ... in the New England Journal of Medicine ...
(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in Bioengineering and Biotechnology 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Fish oil may help the heart beat mental stress 2
... are eating their way through our national forests, destroying ... If enforcement efforts to prevent their importation aren,t stepped ... can expect to fork over billions of dollars by ... BioScience . Researchers at the University of ...
... found aboard the RMS Titanic, which is contributing to ... threat to the exterior of ships and underwater metal ... report their findings in the latest issue of the ... published on 8 December, isolated the micro-organisms from a ...
... a feature unique to humans and pets. Scientists at ... brown trout have individual characters and show different personalities. ... at the University of Gothenburg has for many years ... the west coast of Sweden. "My results show ...
Cached Biology News:Ravenous foreign pests threaten national treasures 2New microscopic life aboard the RMS Titanic 2
... Designed to meet the needs ... animal component-free medium supports fast ... cell densities, while maintaining high ... protein production using the Baculovirus ...
... series of media originally developed at the USDA ... the large scale propagation of cells from the ... for the growth and maintenance of cell lines ... in these cell lines. One of the most ...
... The LIC Duet™ GST•Tag™ Ek Adaptor encodes ... ribosome binding site (rbs), ATG translation initation ... The GST•Tag sequence has been reported to ... the solubility of its fusion partners. The ...
... The LIC Duet™ T7•Tag ® Ek ... operator, ribosome binding site (rbs), ATG ... coding sequence. The T7•Tag is a small ... for detection of the target protein with ...
Biology Products: